Iodine-131
I-131 · Iodine, Z = 53, A = 131
At 4.60e+15 Bq/g — 1.24e+5 Ci/g — a gigabecquerel of I-131 amounts to 217 ng, which is why activity rather than mass is how anyone states the quantity. Iodine-131 decays by beta-minus emission with a half-life of 8.0252 days, falling to 54.63% of today's activity in a week and 0.04% in three months.
An air kerma rate constant of 0.0520 mGy·m²/(GBq·h) is 1.5× less than Cs-137 and 5.9× less than Co-60, and 40 of 96 among the photon emitters carried here.
Halving the air kerma rate calls for 2.34 mm of lead, or 8.91 mm of steel where lead is unwelcome, and a factor of ten calls for 8.79 mm of lead — sheet thicknesses that a glovebox or a transport container can carry. Reaching 20 µSv/h from 1 GBq at a metre takes 3.30 mm of lead.
The beta endpoint is 0.807 MeV, mean 0.182 MeV over 6 branches; that endpoint comes from a branch of only 0.39%, while 89.6% of decays take the 0.606 MeV branch. Shielding is sized on the endpoint, dose on the mean. That endpoint stops in 2.63 mm of acrylic or 1.25 mm of glass. Of the beta energy, 0.14% turns into X-rays in acrylic and 1.74% in lead, worked out for the 0.606 MeV branch, the hardest in at least 1% of decays.
I-131 in thyroid therapy, waste decay and effluent monitoring
I-131 is a fission product, although most of the medical supply is made by neutron irradiation of tellurium, and it is used therapeutically because the thyroid concentrates iodine: administered as iodide, it treats hyperthyroidism and ablates thyroid tissue after cancer surgery. It emits both a beta, which delivers the therapeutic dose locally, and photons, listed below, which make the patient a measurable external source and allow the uptake to be imaged.
The decay table sets the clinical logistics: short enough that ward waste is held for decay rather than shipped, long enough that a treated patient carries measurable activity home. Patient release rules, the handling of excreta and the monitoring of hospital effluent all follow from that balance. Elemental iodine is volatile, so iodide solutions are handled in a fume cupboard and the worker's own thyroid is monitored.
In gamma spectrometry the principal line is distinctive and is one of the first peaks sought after a reactor release, where its short half-life makes it the marker of a recent event. The shielding table here gives the layers for the photon component; the beta is stopped by the first few millimetres of any material and does not reach a person at a distance.
Release criteria for treated patients rest on the dose expected to family members and the public, and countries express them differently: as retained activity, as a dose rate at a stated distance, or through an individual dose assessment. The IAEA guidance on patient release sets out the reasoning that national rules adapt. Excreted I-131 is regularly found in sewage sludge and in rivers below treatment works, which is why some therapy wards route their toilets to delay tanks.
After a reactor accident the protective action specific to this nuclide is thyroid blocking with stable potassium iodide, taken shortly before or within a few hours after exposure, so that stable iodine saturates the gland and blocks further uptake. For staff who dispense therapy activities, a thyroid count with a collimated probe is the routine check that the fume cupboard and the handling procedure are working.
Half-life, specific activity, dose rate and beta energies
| Half-life | 8.0252 days (6.934e+5 s) |
| Decay mode | beta-minus decay |
| Specific activity | 4.60e+15 Bq/g (1.24e+5 Ci/g) |
| Air kerma rate constant Γ (δ = 20 keV) | 0.0520 mGy·m²/(GBq·h) |
| Dose rate, 1 GBq at 1 m | 0.0520 mGy/h |
| Dose rate, 1 Ci at 1 m | 1.92 mGy/h |
| Kerma-weighted mean photon energy | 398.2 keV |
| Beta endpoint / mean | 0.807 MeV / 0.182 MeV |
364 keV leads, and 3 lines make 90%
One further line below the 20 keV cutoff, at 4.54 keV with 0.604% emission probability, is excluded here and from Γ. Probability and dose share.
| Energy (keV) | Emission probability (%) | Share of dose rate (%) |
|---|---|---|
| 364.49 | 81.5 | 76.67 |
| 636.99 | 7.1557 | 11.82 |
| 284.31 | 6.12065 | 4.37 |
| 722.91 | 1.76855 | 3.28 |
| 29.78 | 2.67884 | 1.11 |
| 29.46 | 1.44604 | 0.61 |
| 503.00 | 0.35941 | 0.47 |
| 80.19 | 2.61615 | 0.45 |
| 642.72 | 0.21679 | 0.36 |
| 33.73 | 0.77658 | 0.26 |
| 325.79 | 0.27303 | 0.23 |
| 177.21 | 0.26895 | 0.11 |
| 318.09 | 0.07742 | 0.06 |
| 34.41 | 0.18327 | 0.06 |
Showing the 14 largest contributors of 23 lines above the cutoff; the remainder together carry 0.15% of the dose rate.
2.34 mm of lead halves this spectrum
Solved numerically across all 23 lines, narrow beam. Why not one representative energy.
| Material | HVL (mm) | TVL (mm) | TVL / HVL |
|---|---|---|---|
| lead | 2.34 | 8.79 | 3.76 |
| tungsten | 1.66 | 6.16 | 3.71 |
| iron | 8.91 | 30.7 | 3.44 |
| copper | 7.79 | 26.9 | 3.45 |
| concrete | 29.7 | 102 | 3.42 |
| water | 63.4 | 216 | 3.40 |
| aluminum | 26.7 | 91.3 | 3.42 |
A single energy would give 3.32. Spectrum and attenuation ratios.
2.63 mm of acrylic stops the 0.807 MeV endpoint
Katz–Penfold fit to the 0.807 MeV endpoint — a stopping thickness rather than an attenuation length. Why the material matters more than the thickness.
| Absorber | Range for the endpoint (mm) |
|---|---|
| acrylic | 2.63 |
| aluminum | 1.16 |
| water | 3.13 |
| glass | 1.25 |
The conversion below uses the 0.606 MeV branch; the rarer 0.807 MeV branch sets only the range above.
| Shield material | Fraction of beta energy converted to X-rays |
|---|---|
| acrylic (Z ≈ 6.5) | 0.14% |
| lead (Z = 82) | 1.74% |
Activity over days and weeks
Ten half-lives is 80.3 days — for I-131 itself, a storage problem rather than a disposal one, since those ten half-lives already take it below 0.1% of today's activity. The mean life 1/λ is 11.6 days.
| Elapsed | Fraction remaining |
|---|---|
| 1 half-life | 50.0 % |
| 2 half-lives | 25.0 % |
| 5 half-lives | 3.12 % |
| 10 half-lives | 0.0977 % |
| Time to fall to 10 % of today's activity | 26.7 days |
| Time to fall to 1 % | 53.3 days |
| Time to fall to 0.1 % | 80.0 days |
Limits of these dose rates
- 2.63 mm of acrylic for the 0.807 MeV endpoint: a fitted depth of penetration, not a skin dose.
- Air kerma, 1 µGy counted as 1 µSv — not H*(10).
- Model limits and internal dose.
Gamma, beta and decay calculators for I-131
- Gamma dose rate and shielding
- Beta dose rate and shielding
- Decay and half-life
- Mass and activity
- Detection limits (MDA / MDC)
Other Iodine nuclides: I-125, I-129
Computed from the IAEA Nuclear Data Section — Livechart API (ENSDF) and the NIST X-Ray Mass Attenuation Coefficients. Derivations and citations.